|
G
|
AGT
|
angiotensinogen
|
increases secretion
|
EXP
|
AGT protein results in increased secretion of Progesterone
|
CTD |
PMID:22100847 |
|
NCBI chr14:59,643,030...59,656,835
Ensembl chr14:59,643,292...59,656,833
|
|
G
|
CRABP1
|
cellular retinoic acid binding protein 1
|
affects expression
|
EXP
|
Progesterone affects the expression of CRABP1 protein
|
CTD |
PMID:11833939 |
|
NCBI chr 7:47,602,316...47,608,865
Ensembl chr 7:47,602,192...47,608,970
|
|
G
|
CST3
|
cystatin C
|
affects expression
|
EXP
|
Progesterone affects the expression of CST3 mRNA
|
CTD |
PMID:20107207 |
|
NCBI chr17:30,471,056...30,474,486
Ensembl chr17:30,470,855...30,474,590
|
|
G
|
CTSB
|
cathepsin B
|
increases expression
|
EXP
|
Progesterone results in increased expression of CTSB mRNA
|
CTD |
PMID:20107207 |
|
NCBI chr14:15,014,139...15,035,081
Ensembl chr14:15,011,711...15,033,877
|
|
G
|
CTSL
|
cathepsin L
|
increases expression
|
EXP
|
Progesterone results in increased expression of CTSL mRNA
|
CTD |
PMID:20107207 |
|
NCBI chr10:27,668,523...27,674,705
Ensembl chr10:27,668,264...27,674,618
|
|
G
|
EGFR
|
epidermal growth factor receptor
|
affects chemical synthesis
|
EXP
|
EGFR protein affects the chemical synthesis of Progesterone
|
CTD |
PMID:21520325 |
|
NCBI chr 9:139,302,410...139,474,632
Ensembl chr 9:139,300,022...139,475,589
|
|
G
|
FGF2
|
fibroblast growth factor 2
|
multiple interactions
|
EXP
|
Progesterone inhibits the reaction [estrone benzoate results in decreased expression of FGF2 mRNA]
|
CTD |
PMID:15120423 |
|
NCBI chr 8:101,278,877...101,344,084
Ensembl chr 8:101,278,885...101,343,916
|
|
G
|
FGFR1
|
fibroblast growth factor receptor 1
|
multiple interactions decreases expression
|
EXP
|
estrone benzoate inhibits the reaction [Progesterone results in decreased expression of FGFR1 mRNA alternative form]
|
CTD |
PMID:15120423 |
|
NCBI chr15:48,053,895...48,106,634
Ensembl chr15:48,053,340...48,106,724
|
|
G
|
FGFR2
|
fibroblast growth factor receptor 2
|
decreases expression multiple interactions
|
EXP
|
Progesterone results in decreased expression of FGFR2 mRNA alternative form [Progesterone co-treated with estradiol 3-benzoate] results in decreased expression of FGFR2 mRNA alternative form
|
CTD |
PMID:15120423 PMID:15976484 |
|
NCBI chr14:131,183,095...131,285,001
Ensembl chr14:131,181,713...131,289,425
|
|
G
|
FSHB
|
follicle stimulating hormone subunit beta
|
increases chemical synthesis multiple interactions increases abundance
|
EXP
|
FSHB protein results in increased chemical synthesis of Progesterone 4,4'-bisphenol F inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; [FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone; [FSHB protein co-treated with Lead co-treated with Mercury] results in decreased secretion of Progesterone; bisphenol A inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; bisphenol A promotes the reaction [fisetin inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]]; bisphenol AF inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; bisphenol S inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone]; fisetin inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]; fisetin promotes the reaction [bisphenol A inhibits the reaction [FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone]]; FSHB protein results in increased chemical synthesis of and results in increased secretion of Progesterone; Lapatinib inhibits the reaction [FSHB protein results in increased abundance of Progesterone]; Zearalenone promotes the reaction [FSHB protein results in increased abundance of Progesterone]
|
CTD |
PMID:17656051 PMID:20390873 PMID:20965553 PMID:23375200 PMID:29544186 PMID:34019995 More...
|
|
NCBI chr 2:30,395,769...30,399,282
Ensembl chr 2:30,395,018...30,399,274
|
|
G
|
GHRL
|
ghrelin and obestatin prepropeptide
|
multiple interactions increases secretion decreases secretion
|
EXP
|
Aminoglutethimide promotes the reaction [GHRL protein results in decreased secretion of Progesterone]; GHRL protein results in decreased chemical synthesis of and results in decreased secretion of Progesterone; STAT1 protein inhibits the reaction [GHRL protein results in decreased secretion of Progesterone] GHRL protein results in increased secretion of Progesterone
|
CTD |
PMID:17904772 PMID:19528263 PMID:22341706 |
|
NCBI chr13:66,442,106...66,453,576
Ensembl chr13:66,445,992...66,452,917
|
|
G
|
HOXA10
|
homeobox A10
|
increases expression multiple interactions
|
EXP
|
Progesterone results in increased expression of HOXA10 mRNA Estradiol promotes the reaction [Progesterone results in increased expression of HOXA10 mRNA]
|
CTD |
PMID:21705055 |
|
NCBI chr18:45,393,525...45,403,259
Ensembl chr18:45,393,885...45,403,257
|
|
G
|
IGF1
|
insulin like growth factor 1
|
multiple interactions increases abundance
|
EXP
|
[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone; deoxynivalenol inhibits the reaction [[FSHB protein co-treated with IGF1 protein] results in increased abundance of Progesterone]; Zearalenone promotes the reaction [IGF1 protein results in increased abundance of Progesterone]
|
CTD |
PMID:17656051 |
|
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
|
|
G
|
LEP
|
leptin
|
multiple interactions increases secretion increases expression
|
EXP
|
[TP53 protein co-treated with LEP protein] results in increased secretion of Progesterone Progesterone results in increased secretion of LEP protein Progesterone results in increased expression of LEP mRNA
|
CTD |
PMID:22151798 PMID:23153703 |
|
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
|
|
G
|
LHB
|
luteinizing hormone subunit beta
|
increases abundance multiple interactions
|
EXP
|
LHB protein results in increased abundance of Progesterone daidzein inhibits the reaction [LHB protein results in increased abundance of Progesterone]; Lapatinib inhibits the reaction [LHB protein results in increased abundance of Progesterone]
|
CTD |
PMID:19617652 PMID:23375200 |
|
NCBI chr 6:54,263,574...54,269,286
Ensembl chr 6:54,263,576...54,271,086
|
|
G
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
multiple interactions
|
EXP
|
Progesterone affects the reaction [OXT protein results in increased abundance of Calcium]; Progesterone inhibits the reaction [OXT protein results in increased abundance of Dinoprost]; Progesterone inhibits the reaction [OXT protein results in increased secretion of Dinoprost]; Progesterone inhibits the reaction [OXT protein results in increased secretion of Dinoprostone]; Progesterone inhibits the reaction [OXT protein results in increased transport of Calcium]
|
CTD |
PMID:16997130 PMID:21370738 |
|
NCBI chr17:32,605,586...32,606,449
Ensembl chr17:32,605,586...32,606,546
|
|
G
|
PLAU
|
plasminogen activator, urokinase
|
increases expression
|
EXP
|
Progesterone results in increased expression of PLAU mRNA
|
CTD |
PMID:23103014 |
|
NCBI chr14:76,629,313...76,635,173
Ensembl chr14:76,629,299...76,635,172
|
|
G
|
POMC
|
proopiomelanocortin
|
increases secretion
|
EXP
|
POMC protein results in increased secretion of Progesterone
|
CTD |
PMID:22100847 |
|
NCBI chr 3:113,661,712...113,668,558
Ensembl chr 3:113,661,004...113,670,418
|
|
G
|
RBP4
|
retinol binding protein 4
|
affects expression
|
EXP
|
Progesterone affects the expression of RBP4 protein
|
CTD |
PMID:11833939 |
|
NCBI chr14:105,037,360...105,044,552
Ensembl chr14:105,037,464...105,044,765
|
|
G
|
STAT1
|
signal transducer and activator of transcription 1
|
multiple interactions
|
EXP
|
STAT1 protein inhibits the reaction [GHRL protein results in decreased secretion of Progesterone]
|
CTD |
PMID:19528263 |
|
NCBI chr15:95,593,201...95,646,324
Ensembl chr15:95,593,211...95,646,260
|
|
G
|
TP53
|
tumor protein p53
|
multiple interactions decreases secretion
|
EXP
|
[TP53 protein co-treated with LEP protein] results in increased secretion of Progesterone TP53 protein results in decreased secretion of Progesterone
|
CTD |
PMID:22151798 |
|
NCBI chr12:52,939,643...52,953,786
Ensembl chr12:52,939,644...52,953,818
|
|